middle.news
How Is Cyclopharm Driving Rapid US Expansion of Technegas® Lung Imaging?
8:50am on Tuesday 31st of March, 2026 AEDT
•
Healthcare
Read Story
How Is Cyclopharm Driving Rapid US Expansion of Technegas® Lung Imaging?
8:50am on Tuesday 31st of March, 2026 AEDT
Key Points
50 revenue-generating Technegas® installations in the US
New multi-site contracts with leading health systems including MUSC and Stony Brook
Expansion within Veterans Affairs hospitals continues
Clinical guidelines expected to endorse Technegas® as preferred ventilation imaging agent
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CYCLOPHARM (ASX:CYC)
OPEN ARTICLE